je.st
news
Galena Biopharma Earns "Buy" Rating from Roth Capital
2015-05-24 06:48:06| Biotech - Topix.net
's stock had its "buy" rating reiterated by equities researchers at Roth Capital in a research report issued on Friday. They currently have a $8.00 price target on the biotechnology company's stock.
Tags: buy
rating
capital
roth
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||